Concepedia

Karyopharm Therapeutics (United States)

KT

Statistics

Publications

875

Citations

93.4K

Authors

54

Location

Newton, United States

Karyopharm Therapeutics (United States) is a company institution in Newton, United States known for medicine, oncology, and molecular oncology.

HomepageROR

Top concepts

Publications

875

Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou et al. · New England Journal of Medicine · 2019 · 673 citations · Full text

, , +15

Genomic and molecular characterization of esophageal squamous cell carcinoma

De‐Chen Lin, Jia‐Jie Hao, Yasunobu Nagata et al. · Nature Genetics · 2014 · 662 citations · Full text

, , +14

Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial

Marc André, T. Girinsky, Massimo Federico et al. · Journal of Clinical Oncology · 2017 · 532 citations · Full text

, , +17

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

Mattia D’Agostino, David A. Cairns, Juan José Lahuerta et al. · Journal of Clinical Oncology · 2022 · 407 citations · Full text

, , +15

Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

Nagesh Kalakonda, Marie Maerevoet, Federica Cavallo et al. · The Lancet Haematology · 2020 · 337 citations · Full text

, , +11

1–5 of 875

Authors

54

  1. SS
    Sharon Shacham

    Karyopharm Therapeutics (United States), United States

    559 publications · 12.6K citations

    62

    h-index

  2. MK
    Michael Kauffman

    Karyopharm Therapeutics (United States), United States

    432 publications · 13.8K citations

    56

    h-index

  3. YL
    Yosef Landesman

    Karyopharm Therapeutics (United States), United States

    451 publications · 7K citations

    45

    h-index

  4. EB
    Erkan Baloglu

    Karyopharm Therapeutics (United States), United States

    230 publications · 5.5K citations

    38

    h-index

  5. WS
    William Senapedis

    Karyopharm Therapeutics (United States), United States

    203 publications · 3.7K citations

    34

    h-index

1–5 of 54